Similar businesses sell at 1.4x to 7.5x SDE. Compare live listings and connect with sellers.
B2B tech dealer specializing in providing restaurant management systems for a wide variety of restaurant businesses including table service, quick service, bars and nightclubs, pizzerias, coffee shops, enterprise-based establishments, and venues (ticketing, concessions and mobile ordering). The business provides software, hardware with mobile options, cameras / CCTV, and management tools which provide owners with control over their businesses via advanced reporting and back office tools. Owner currently spends only 10-20 hours a week on this easy to run business with excellent margins. Seller has only owned the company for 1 year and has to sell due to an urgent family matter. Very knowledgeable technician employee committed to stay on with new owner. Contact us today and continue to build on this business's impressive track record and grow sales even more than Seller has accomplished in only 1 year! Partial / minimum seller financing possible with strong offer.
Founded in 2008, this highly reputable, premium brand, full-service digital marketing and development agency is located in the Nashville market. The company has demonstrated consistent year-over-year growth, maintains a 4.9-star Google rating, and ranks #1 for multiple high-value search terms in Nashville. The business generates strong inbound demand, receiving an average of 2–5 organic referrals per week from ChatGPT and Google searches alone. No heavy paid advertising dependency. Core Services Include: • Website design & development • App development • Lead generation • Branding & graphic design • Content development • Marketing technology integration • Social media management • High-end video production (in-house department) The company operates 100% remotely as of December 31, 2024, eliminating office overhead and increasing profitability. A premium six-figure domain name and federally protected trademark are included in the sale. The brand is highly scalable and positioned for regional or national expansion. In addition to the established agency model, the company is developing its .AI domain, creating potential for recurring revenue, SaaS offerings, and platform-based growth opportunities. Ideal Buyer: • Owner-operator with industry experience • Strategic bolt-on acquisition • Agency seeking Nashville market expansion • Buyer looking for strong organic lead flow and brand equity The current owner spends approximately 4–5 hours per day in oversight and client coordination. Transfer of existing EIDL loan available (partial financing option). Must have funding in place. Owner financing is not available nor is traditional SBA financing. Serious inquiries only.
This firm develops life science research tools enabling autonomous, non-invasive, real-time monitoring of compound bioavailability, biological events, or viability/metabolic dynamics from any cell using a proprietary synthetic luciferase technology that does not require external stimulation to function. The Company’s products are immediately relevant to discovery phase pharmacology programs as an improved method for accessing the toxicity and metabolic impact of potential new drug compounds and to in vitro and in vivo basic research and development activities for interrogating tumor formation, progression, and recession, cellular health, motility, localization, or transcriptional activity. Their patent protected synthetic luciferase removes the need for external stimulation that limits current fluorescent and bioluminescent imaging approaches. Unlike previous technologies, it can automatically turn on or off light production to indicate biomarker transcription or changes in differentiation state, continuously emit harmless visible light to enable persistent localization and viability tracking, or autonomously adjust signal intensity to reflect real-time changes in metabolism, toxicity, or any other desired cellular metric. This solves the problems of uneven excitation and emission in 3D culture applications, allows the distribution, health, and propagation of implanted cells to be tracked in real-time in small animal models, and removes the need to sacrifice precious in vitro samples concurrent with luciferin exposure. As a simple genetic technology, their synthetic luciferase can be delivered using the same transfection approaches as older fluorescent/luminescent genes and expression can be regulated using any transcriptional or synthetic biology control architecture. This drop-in replacement capability, combined with improved functionality, enables exciting new capabilities, and accelerates existing research by producing more data, reducing costs, and enabling continuous automated tracking without requiring perturbation at any point throughout the data collection process. The purchase of this company includes patents, ready-to-ship product inventory, the bacterial stocks required to make more of the products, all scientific lab notebooks from R&D operations, and company intelligence data. The value is based on the "cost to recreate" and projections based on requests. The products are ready for orders and in demand by some of the world’s largest biotech companies and most respected researchers. This company has recently completed the vetting process to have their products featured in the Thermo Fisher Scientific catalogue. A key element necessary for growth and marketing of the products is an experienced business development team. Orders can be worth $1mm each large client within the first 5 years.
National transaction benchmarks for online and technology business businesses.
Under $500K
$500K to $2M
Over $2M
A variety of factors can cause businesses to trade outside this range, including earnings quality, operational transferability, key-person risk, growth trajectory, and geography, so a listing priced above or below the typical multiple usually reflects real differences in the underlying business.
Cofounder & CEO
Key diligence, valuation, financing, and transition considerations for buyers evaluating online and technology business acquisitions.
Do not rely on a profit-and-loss screenshot. Get read access to the payment processor, the ad accounts, the bank, and analytics, and reconcile reported revenue against processor payouts for at least the trailing twelve months.
Most online businesses depend on one channel: search, paid social, a marketplace, or an app store. Ask what share of revenue rides on it and what a ranking or policy change would do.
For subscription and SaaS models, gross and net revenue retention matter more than the top line. Growth on new customers while existing ones churn is worth far less than the headline.
A handful of accounts or a single manufacturer can carry the whole business. Quantify what happens if the largest customer or supplier walks.
Identify who owns the code, the domains, the ad pixels, and the key integrations. Founder-built systems with no documentation are a transition risk you price in, not ignore.
Many small online businesses are one person doing content, fulfillment, and support. Get specific about what the seller does each week and what it would cost to replace them.
Answers to common buyer questions for this market.
